Showing 1391-1400 of 1735 results for "".
- Johnson & Johnson Vision Launches the UK’s First Free Nationwide Recycling Program for all Contact Lenseshttps://modernod.com/news/johnson-johnson-vision-launches-the-uks-first-free-nationwide-recycling-program-for-all-contact-lenses/2476189/Johnson & Johnson Vision has launched the Acuvue Contact Lens Recycle Program, the UK’s first free nationwide program that enables consumers to easily recycle their contact lenses and the blister and foil packaging after use. The program is available to all soft contact lens wearers reg
- Ace Vision Group Adds Four Ophthalmologists to Medical Advisory Board; Launches New Corporate and Medical Affairs Websiteshttps://modernod.com/news/ace-vision-group-adds-four-ophthalmologists-to-medical-advisory-board-launches-new-corporate-and-medical-affairs-websites/2481941/Ace Vision Group announced the addition of Cathleen McCabe, MD; James Katz, MD; Ehsan Sadri, MD; and Dagny Zhu, MD, to its medical advisory board. These prominent ophthalmologists will contribute expertise to advance the development and implementation of novel solutions for e
- Sun Pharma to Acquire Organon in $11.75 Billion All-Cash Dealhttps://modernod.com/news/sun-pharma-to-acquire-organon-in-1175-billion-all-cash-deal/2486921/Key Takeaways
- Zeiss Acquires All Shares of Tooz, Maker of Augmented Reality Opticshttps://modernod.com/news/zeiss-acquires-tooz-maker-of-augmented-reality-and-virtual-reality-glasses/2481447/Zeiss announced it has acquired the shares of the joint venture tooz technologies, which was founded together with Deutsche Telekom in 2018 and is developer of high-tech optics in the area of augmented reality. Until now, Zeiss and Deutsche Telekom held 50% of the shares in the sta
- Akorn Files for Chapter 7 Bankruptcy; to Close All US Siteshttps://modernod.com/news/akorn-pharma-to-close-all-us-sites/2481445/Akorn Pharmaceuticals, a maker of generic and branded drugs, announced it is ceasing operations. The company, which offered more than 20 ophthalmic products, has filed for chapter 7 bankruptcy and is shutting down US operations. The news was first
- Artificial Intelligence in Ophthalmology: A Brave New World Cominghttps://modernod.com/news/artificial-intelligence-in-ophthalmology-a-brave-new-world-coming/2479934/Artificial intelligence (AI) has been heralded as part of “the fourth industrial revolution,” along with Internet of Things, blockchain, and edge computing. All are methods of collecting, analyzing, and storing information and viewed as possessing the same life-changing potential as t
- EyePoint Pharmaceuticals Reports Positive 30-Day Safety Results for All Cohorts From DAVIO Trial of EYP-1901 for Wet AMDhttps://modernod.com/news/eyepoint-pharmaceuticals-reports-positive-30-day-safety-results-for-all-cohorts-from-the-davio-trial-of-eyp-1901-for-wet-amd/2479344/EyePoint Pharmaceuticals announced positive safety results from its phase 1 clinical trial of EYP-1901, a potential twice-yearly sustained delivery anti-VEGF treatment targeting wet age-related macular degeneration (AMD). All dose cohorts have reached at least 30-day post-dosing foll
- Early Study Shows J&J’s One-Dose COVID-19 Vaccine Triggered Antibodies in all Participantshttps://modernod.com/news/early-study-shows-jjs-one-dose-covid-19-vaccine-triggered-antibodies-in-all-participants/2478759/Detailed phase 1/2a study findings published in the NEJM on Wednesday showed that all volunteers given Johnson & Johnson’s single-dose coronavirus vaccine Ad26.COV2.S had detectable neutralizing antibodies by day 57. In September, the company reported a preview of the interim results in
- AGTC Announces Completion of Enrollment in All Adult Dose Groups of its Ongoing Phase 1/2 Clinical Trials in Patients with Achromatopsiahttps://modernod.com/news/agtc-announces-completion-of-enrollment-in-all-adult-dose-groups-of-its-ongoing-phase-1-2-clinical-trials-in-patients-with-achromatopsia/2477389/Applied Genetic Technologies Corporation (AGTC) announced that it has completed the planned enrollment in all dose groups for adult patients (age 18 years or older), including the two higher dose groups, of its phase 1/2 clinical programs with achromatopsia due to mutation in the
- TearRestore Announces First of Its Kind Dry Eye Solutions; Now Available at Walmarthttps://modernod.com/news/tearrestore-announces-first-of-its-kind-dry-eye-solutions-now-available-at-walmart/2481643/TearRestore announced that its Thermal Mask and Eyelid Wipes will now be available at participating Walmart stores nationwide and at Walmart.com. Both products will be available for recommendation for dry eye by Walmart’s in-store optometrists. &ldqu